Physician profile
Ben Tacheron
NPI 1154303493
$1,451.36
in general payments reported to CMS, 2019-2025
20 companies · $18.48 in 2025
The $18.48 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.24 · 2020: $25.29 · 2021: $17.62 · 2022: $214 · 2023: $999 · 2024: $78.08 · 2025: $18.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $707.81 | 2022-2024 | Proclaim, Eterna, Axium |
| Collegium Pharmaceutical, INC. | $150.68 | 2023-2024 | Belbuca |
| Boston Scientific Corporation | $83.37 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $79.68 | 2023 | Qutenza |
| Lundbeck LLC | $67.45 | 2023 | Vyepti |
| Abbvie INC. | $60.09 | 2020-2023 | Botox |
| Amgen INC. | $43.84 | 2019 | |
| Supreme Orthopedic Systems, LLC | $30.34 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $29.17 | 2023 | Seglentis |
| Nevro Corp. | $26.38 | 2023 | Senza |
| Medtronic, INC. | $25.73 | 2024 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $20.68 | 2023 | Triluron |
| Vertos Medical, INC. | $20.60 | 2023 | Mild Device Kit |
| Chiesi USA, INC. | $18.48 | 2025 | Cleviprex |
| Intercept Pharmaceuticals, INC. | $17.62 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.50 | 2019 | |
| Allergan, INC. | $14.08 | 2019 | |
| Relievant Medsystems, INC. | $14.04 | 2023 | Intracept |
| Teva Pharmaceuticals USA, INC. | $13.84 | 2019 | |
| Biodelivery Sciences International, INC. | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Tacheron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.